- Home
- RVPH vs EPOW Comparison
RVPH vs EPOW Comparison
Compare RVPH & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- EPOW
- Stock Information
- Founded
- RVPH 2006
- EPOW 2014
- Country
- RVPH United States
- EPOW China
- Employees
- RVPH N/A
- EPOW N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- EPOW Business Services
- Sector
- RVPH Health Care
- EPOW Consumer Discretionary
- Exchange
- RVPH Nasdaq
- EPOW Nasdaq
- Market Cap
- RVPH 26.6M
- EPOW 24.8M
- IPO Year
- RVPH N/A
- EPOW 2021
- Fundamental
- Price
- RVPH $0.47
- EPOW $0.90
- Analyst Decision
- RVPH Strong Buy
- EPOW
- Analyst Count
- RVPH 5
- EPOW 0
- Target Price
- RVPH $9.00
- EPOW N/A
- AVG Volume (30 Days)
- RVPH 3.2M
- EPOW 17.7K
- Earning Date
- RVPH 08-13-2025
- EPOW 08-05-2025
- Dividend Yield
- RVPH N/A
- EPOW N/A
- EPS Growth
- RVPH N/A
- EPOW N/A
- EPS
- RVPH N/A
- EPOW N/A
- Revenue
- RVPH N/A
- EPOW $64,997,741.00
- Revenue This Year
- RVPH N/A
- EPOW N/A
- Revenue Next Year
- RVPH N/A
- EPOW N/A
- P/E Ratio
- RVPH N/A
- EPOW N/A
- Revenue Growth
- RVPH N/A
- EPOW 44.28
- 52 Week Low
- RVPH $0.30
- EPOW $0.55
- 52 Week High
- RVPH $4.28
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- RVPH 45.52
- EPOW 45.25
- Support Level
- RVPH $0.44
- EPOW $0.87
- Resistance Level
- RVPH $0.53
- EPOW $0.95
- Average True Range (ATR)
- RVPH 0.04
- EPOW 0.04
- MACD
- RVPH 0.02
- EPOW -0.01
- Stochastic Oscillator
- RVPH 49.00
- EPOW 14.59
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.